arGentis Pharmaceuticals competitorsClear all

arGentis Pharmaceuticals's top competitors include Opiant Pharmaceuticals, E-Therapeutics and Horizon Therapeutics.
arGentis Pharmaceuticals
arGentis Pharmaceuticals
arGentis Pharmaceuticals is a pharmaceutical company focused on autoimmune disease treatments.
Opiant Pharmaceuticals
Opiant Pharmaceuticals
Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
E-Therapeutics
E-Therapeutics
e-Therapeutics is a drug discovery and development company based in Oxford and Newcastle, UK. The Company is a pioneer of network pharmacology, a distinctive new approach to the discovery of medicines.
Horizon Therapeutics
Horizon Therapeutics
Horizon Therapeutics is a biopharmaceutical company building a pipeline and exploring potential uses for medicines.
Founding Date
Founding Date
2007
Founding Date
2009
Founding Date
2003
Founding Date
2008
Type
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Collierville, US HQ
Collierville, US
Locations
Santa Monica, US HQ
London, GB
Santa Monica, US
Locations
Long Hanborough, GB HQ
Newcastle Upon Tyne, GB
Locations
Ballsbridge, IE HQ
Mannheim, DE
Chicago, US
Lake Forest, US
Novato, US
South San Francisco, US
Washington, US
Employees
Employees
N/A
Employees
2131% increase
Employees
2017% decrease
Employees
1,20020% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
39.1 m
Valuation ($)
N/A
Valuation ($)
15.7 b
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
241358
Alexa Website Rank
367320
Alexa Website Rank
269814

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$40.5m (FY, 2019)
Revenue (est.)
£44k (FY, 2019)
Revenue (est.)
$1.3b (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$362.2m (FY, 2019)
Gross profit
Gross profit
N/A
Gross profit
$40.5m (FY, 2019)
Gross profit
N/A
Gross profit
$937.9m (FY, 2019)
Net income
Net income
N/A
Net income
$11.6m (FY, 2019)
Net income
(£4m) (FY, 2019)
Net income
$573m (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 500k
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 63m
For sources of this data, please see the company profile

View company profiles

Opiant Pharmaceuticals
HQ
Santa Monica, US
Employees
21↑ 31% increase

Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.

View company
E-Therapeutics
HQ
Long Hanborough, GB
Employees
20↓ 17% decrease

e-Therapeutics is a drug discovery and development company based in Oxford and Newcastle, UK. The Company is a pioneer of network pharmacology, a distinctive new approach to the discovery of medicines.

View company
Horizon Therapeutics
HQ
Ballsbridge, IE
Employees
1,200↑ 20% increase

Horizon Therapeutics is a biopharmaceutical company building a pipeline and exploring potential uses for medicines.

View company